| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Long term restricted deposit | 11 | |||
| Property and equipment, net | 29 | |||
| Operating right of use asset | 45 | |||
| Total non-current assets | 85 | |||
| Cash and cash equivalents | 63 | |||
| Accounts receivable | 27 | |||
| Total current assets | 90 | |||
| Total assets | 175 | |||
| Trade and other payables | 393 | |||
| Stockholders loans | 176 | |||
| Convertible loans from related parties | 32 | |||
| Deferred grant income | 173 | |||
| Total current liabilities | 774 | |||
| Long term lease liability | 26 | |||
| Total non-current liabilities | 26 | |||
| Total liabilities | 800 | |||
| Accumulated deficit | -18,212 | |||
| Common stock, par value 0.001 per share, 600,000,000 shares authorized as of june 30, 2025, and december 31, 2024. 77,238,961 and 71,008,144 shares issued as of june 30, 2025, and december 31, 2024, respectively | 77 | |||
| Additional paid-in capital | 17,510 | |||
| Total stockholders deficit | -625 | |||
| Total liabilities and stockholders deficit | 175 | |||
IR-Med, Inc. (IRME)
IR-Med, Inc. (IRME)